Alec Barclay - 20 Feb 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Operations Officer
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
20 Feb 2022
Net transactions value
-$2,458
Form type
4
Filing time
23 Feb 2022, 18:42:20 UTC
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +10,000 +13% 84,420 21 Feb 2021 Direct F1
transaction TTOO Common Stock Tax liability $2,458 -5,275 -6.2% $0.4660 79,145 21 Feb 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +600,000 $0.000000 600,000 20 Feb 2022 Common Stock 600,000 Direct F1, F3
transaction TTOO Restricted Stock Units Options Exercise $0 -10,000 -100% $0.000000* 0 21 Feb 2022 Common Stock 10,000 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F3 On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2022.
F4 On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments commencing on February 21, 2020..